This is a community-generated profile. If you would like to claim it, please .
OptiScan Biomedical Funding
$64.7M
33 rounds
OptiScan Biomedical is active in the following markets / industries: biotechnology. The company has secured funding across 3 rounds, totaling in an amount of $64.7M. Their most recent funding was raised on February 7, 2013.
Funding Rounds
U
$30700000U
$2500000U
$31500000Investors of OptiScan Biomedical
Ben duPont
Partner at Chartline Capital Partners, a special situations venture capital fund. Co-founder of; yet2Ventures, yet2.com and Zip Code Wilmington